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Abstract
Background: Microglial activation plays an important role in neurodegenerative diseases by producing several
proinflammatory enzymes and proinflammatory cytokines. The phenolic glucoside gastrodin, a main constituent of a
Chinese herbal medicine, has been known to display anti-inflammatory properties. The current study investigates the
potential mechanisms whereby gastrodin affects the expression of potentially pro-inflammatory proteins by cultured
murine microglial BV-2 cells stimulated with lipopolysaccharide (LPS).
Methodology/Principal Findings: BV-2 cells were pretreated with gastrodin (30, 40, and 60 mM) for 1 h and then stimulated
with LPS (1 mg/ml) for another 4 h. The effects on proinflammatory enzymes, inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX-2), and proinflammatory cytokines, tumor necrosis factor-a (TNF-a), and interleukin-1b (IL-1b), are
analysed by double-immunofluorescence labeling and RT-PCR assay. To reveal the mechanisms of action of gastrodin we
investigated the involvement of mitogen-activated protein kinases (MAPKs) cascades and their downstream transcription
factors, nuclear factor-kB (NF-kB) and cyclic AMP-responsive element (CRE)-binding protein (CREB). Gastrodin significantly
reduced the LPS-induced protein and mRNA expression levels of iNOS, COX-2, TNF-a, IL-1b and NF-kB. LPS (1 mg/ml,
30 min)-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK)
and p38 mitogen-activated protein kinase (p38 MAPK) and this was inhibited by pretreatment of BV-2 cells with different
concentrations of gastrodin (30, 40, and 60 mM). In addition, gastrodin blocked LPS-induced phosphorylation of inhibitor
kB-a (IkB-a) (and hence the activation of NF-kB) and of CREB, respectively.
Conclusion and Implications: This study indicates that gastrodin significantly attenuate levels of neurotoxic
proinflammatory mediators and proinflammatory cytokines by inhibition of the NF-kB signaling pathway and
phosphorylation of MAPKs in LPS-stimulated microglial cells. Arising from the above, we suggest that gastrodin has a
potential as an anti-inflammatory drug candidate in neurodegenerative diseases.
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Introduction
Microglial cells are the resident macrophage-like population of
cells, which has been proposed to play a pivotal role in the innate
immune response in the central nervous system (CNS) [1].
Although activated microglia scavenge dead cells from the CNS
and secrete different neurotrophic factors for neuronal survival
[2,3,4], it is believed that severe activation causes various
autoimmune responses leading to neuronal death and brain injury
[5,6]. Activation of microglia has been implicated in the
pathogenesis of variety of neurodegenerative diseases, including
multiple sclerosis, Parkinson’s disease, Huntington’s disease, and
Alzheimer’s disease [7,8,9]. Activation of microglia and conse-
quent release of proinflammatory and/or cytotoxic factors such as
tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b), nitric
oxide (NO), reactive oxygen species (ROS), inducible nitric oxide
synthase (iNOS), and cyclooxygenase-2 (COX-2) are believed to
contribute to neurodegenerative processes [10,11,12,13].
iNOS is not normally expressed in the brain, but inflammatory
stimuli such as lipopolysaccharide (LPS) and cytokines cause its
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21891expression in microglia and astrocytes [14]. Once expressed, iNOS
produces high levels of NO continuously [15]. A number of studies
have shown that the iNOS along with the release of NO by
activated microglia contributes to progress neurodegeneration and
aggravate neuronal diseases [16]. NO activates COX-2 resulting
in the increased release of proinflammatory prostaglandins [17].
Induction of COX-2 expression and enzymatic activity can be
associated with the management of inflammation and several
neuronal diseases [18].
It has recently been suggested that the activation of microglia
can increase neurotoxicity through the production of proinflam-
matory and cytotoxic factors in neuron-glia cultures treated with
LPS, b-amyloid, glutamate, and arachidonate [19]. One of these
widely used stimuli is LPS, a bacterial endotoxin used to study
experimentally induced infection, inflammation, or tissue damage,
as well as the biochemistry of inflammatory responses. LPS
activates nuclear factor-kB (NF-kB), cyclic AMP responsive
element-binding protein (CREB) and mitogen-activated protein
kinases (MAPKs) family, which are classified into at least three
components: extracellular signal-regulated kinases (ERKs), c-Jun
N-terminal kinase (JNK), and p38 MAPK [20], which have been
implicated in the release of immune-related cytotoxic factors such
as iNOS, COX-2, and proinflammatory cytokines [12,21].
The phenolic glucoside gastrodin (Figure 1), the main active
ingredient of an ancient Chinese herb Tianma (Gastrodia elata
Bl.), is considered to have several beneficial properties. Gastrodin
has been suggested to be effective as an anticonvulsant, analgesic,
and sedative effective against vertigo, general paralysis, epilepsy,
and tetanus [22]. Gastrodin could penetrate through the blood-
brain barrier into brain, and it was rapidly decomposed to
p-hydroxybenzyl alcohol (HBA) in brain, liver, and blood [23]. It is
well known that gastrodin ameliorates cerebral damage after
transient focal cerebral ischemia by promoting the ability to
reduce ROS damage in vivo and hippocampal neuronal death and
excitotoxicity in vitro [24] and has a neuroprotective action against
hypoxia in the cultured cortical neuron [25]. There are numerous
reports in the literature show that gastrodin and HBA, an aglycone
of gastrodin, may improve learning and facilitate memory
consolidation and retrieval [26,27]. There is, however, no report
on the bioactive principles and the detailed mechanisms
responsible for the anti-inflammatory activity of this herbal plant.
In the present study, we attempted to elucidate the anti-
inflammatory potential of gastrodin by investigating the effect of
gastrodin on the inflammatory response induced by LPS in murine
microglial BV-2 cells. To further investigate the underlying
mechanisms, the involvement of CREB, NF-kB and MAPKs
was also examined. The present study provides information
revealing gastrodin as a potential candidate compound with anti-
inflammatory actions and suggests a scientific basis for further
investigation of gastrodin against neuroinflammatory conditions.
Results
Gastrodin inhibits LPS-stimulated expression of iNOS and
COX-2 proteins and mRNA in BV-2 cells
To investigate the effect of gastrodin on LPS-stimulated micro-
glial activation, BV-2 cells were stimulated with LPS (1 mg/ml)
which resulted in increase of the protein and mRNA levels of iNOS
(Figure 2). Pre-treatment with gastrodin (30, 40, and 60 mM) notably
inhibited dose-dependently iNOS protein and mRNA levels
(Figure 2), compared with LPS-treated control.
Effect of gastrodin on another proinflammatory enzyme, COX-
2 was examined by double-immunofluorescence labeling and RT-
PCR assay. Stimulation of BV-2 cells with LPS led to increased
expression of protein and mRNA for COX-2 (Figure 3). Gastrodin
dose-dependently decreased the increased expression of COX-2
protein and mRNA stimulated by LPS (Figure 3).
Gastrodin attenuates LPS-stimulated the production of
the proinflammatory cytokines TNF-a and IL-1b at the
transcriptional and translational levels in BV-2 cells
To investigate whether gastrodin represses the production of
these proinflammatory cytokines, which play central roles in
inflammatory disease, BV-2 cells were stimulated with LPS (1 mg/
ml) in the presence or absence of gastrodin (30, 40, and 60 mM).
After treatment with LPS, the protein levels of the cytokines in
BV-2 cells were measured. The protein levels of TNF-a and IL-1b
increased in LPS-stimulated BV-2 cells. Pre-treatment with
gastrodin resulted in a significant decrease in cytokine production
(Figure 4A and 5A).
To further investigate whether the inhibitory effect of gastrodin
on TNF-a and IL-1b production is due to the reduced expression
of cognate genes, the effect of gastrodin on mRNA expression of
TNF-a and IL-1b was assessed in LPS-stimulated BV-2 cells. As
shown in Figure 4B and 5B, the mRNA expression of these
inflammatory mediators was very low or hardly detectable in
unstimulated BV-2 cells. However, BV-2 cells expressed high
levels of TNF-a and IL-1b mRNA when stimulated with LPS
(1 mg/ml). Furthermore, gastrodin suppressed LPS-induced ex-
pression of these genes in a concentration-dependent manner. In
contrast, the level of b-actin mRNA was not affected by LPS and
gastrodin treatment (Figure 4B and 5B).
Gastrodin suppresses LPS-induced expression of NF-kB/
RelA protein, phosphorylation of IkB-a and CREB in BV-2
cells
To further elucidate the mechanisms of gastrodin on the
inhibition of expression of iNOS, COX-2, and proinflammatory
cytokines in microglia, the study examined the effect of gastrodin
on NF-kB and CREB, two major transcription factors involved in
the expression of these inflammatory mediators. The processes of
NF-kB activation include IkB-a degradation through phosphor-
ylation and a subsequent nuclear translocation of NF-kB. We
determined whether the inhibitory effects of gastrodin occurred
through the blockade of NF-kB activation in BV-2 cells. LPS
induced expression of NF-kB/RelA protein and mRNA within
4 h after stimulation, which was inhibited by gastrodin (Figure 6).
Meanwhile, as shown in Figure 7A, pre-treatment of gastrodin (30,
40, and 60 mM) suppressed the LPS induced phosphorylation of
IkB-a.
CREB is the physiological substrate for MAPKs and stress-
activated protein kinases-1 (MSK1), which is activated by ERK
and p38 MAPK-mediated signaling in response to LPS. CREB
activation was markedly stimulated by LPS, and this activation
Figure 1. Structure of gastrodin.
doi:10.1371/journal.pone.0021891.g001
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three concentrations (Figure 7B).
Gastrodin decreases LPS-induced phosphorylation of
MAPKs family in BV-2 cells
The effect of gastrodin on MAPKs, which are upstream
signaling molecules in inflammatory reactions, was examined in
the LPS-stimulated BV-2 cells. Western blot analysis was carried
out using the phospho- or total forms of antibodies against the
three MAPKs, ERK1/2, JNK, and p38 MAPK. It was observed
that gastrodin (30, 40, and 60 mM) remarkably decreased the LPS-
stimulated phosphorylation of ERK1/2 at 30 min, respectively,
whereas it had no effect on the expression level of ERK1/2 in
LPS-stimulated BV-2 cells. (Figure 7C). Meanwhile, gastrodin at
all concentrations used significantly suppressed the phosphoryla-
tion of JNK and p38 MAPK, respectively, but did not affect the
Figure 2. Inhibitory effects of gastrodin on the LPS-induced expression of protein and mRNA for iNOS in BV-2 cells. Approximately
1610
6 cells/ml were seededin six-wellplatesandincubateduntil80%confluency.Cellswere pre-treated withgastrodin (30, 40, and60 mM)for1 h,then
exposed to 1 mg/ml LPS for 4 h. The levels of protein and the corresponding mRNA were determined by double-immunofluorescence labeling and RT-
PCR as described in the Methods. PanelA showsthe immunofluorenscence images for protein expression of iNOS and PanelB shows the corresponding
mRNA data. The relative mRNA level was quantified by scanning densitometry and normalized to b-actin mRNA. The values shown are mean 6 SEM of
data from three independent experiments.
# Significant compared with control alone, p,0.05.
*Significant compared with LPS alone, p,0.05.
doi:10.1371/journal.pone.0021891.g002
Figure 3. Inhibitory effects of gastrodin on the LPS-induced expression of protein and mRNA for COX-2 in BV-2 cells. Approximately
1610
6 cells/ml were seeded in six-well plates and incubated until 80% confluency. Cells were pre-treated with gastrodin (30, 40, and 60 mM) for 1 h, then
exposedto1 mg/mlLPSfor4 h.ThelevelsofproteinandthecorrespondingmRNAweredeterminedbydouble-immunofluorescencelabelingandRT-PCR
as described in the Methods. Panel A shows the immunofluorenscence images for protein expression of COX-2 and Panel B shows the corresponding
mRNA data. The relative mRNA level was quantified by scanning densitometry and normalized to b-actin mRNA. The values shown are mean 6 SEM of
data from three independent experiments.
# Significant compared with control alone, p,0.05.
*Significant compared with LPS alone, p,0.05.
doi:10.1371/journal.pone.0021891.g003
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cells (Figure 7D and 7E).
Discussion
Microglial activation has both beneficial and harmful effects on
neuronal cell survival [28]. However, there are multiple lines of
evidence suggesting that microglial activation is more associated
with neurodegenerative diseases such as Alzheimer’s disease and
Parkinson’s disease [29,30]. Over-activation of microglia contrib-
utes to neurodegenerative processes through the production of
various neurotoxic factors including free radicals and proinflam-
matory cytokines [31]. Therefore, inhibition of microglial
activation may be a potential therapeutic strategy to reduce
neuronal cell death. In fact, a number of anti-inflammatory agents,
which inhibit microglial activation or production of proinflamma-
Figure 4. Inhibitory effects of gastrodin on the LPS-induced expression of protein and mRNA for TNF-a in BV-2 cells. Approximately
1610
6 cells/ml were seeded in six-well plates and incubated until 80% confluency. Cells were pre-treated with gastrodin (30, 40, and 60 mM) for 1 h, then
exposed to 1 mg/ml LPS for 4 h. Thelevels of protein and thecorresponding mRNA were determined by double-immunofluorescence labeling and RT-PCR
asdescribedintheMethods.PanelAshowstheimmunofluorenscenceimagesforproteinexpressionofTNF-aand Panel B showsthecorresponding mRNA
data. The relative mRNA level was quantified by scanning densitometry and normalized to b-actin mRNA. The values shown are mean 6 SEM of data from
three independent experiments.
# Significant compared with control alone, p,0.05.
*Significant compared with LPS alone, p,0.05.
doi:10.1371/journal.pone.0021891.g004
Figure 5. Inhibitory effects of gastrodin on the LPS-induced expression of protein and mRNA for IL-1b in BV-2 cells. Approximately
1610
6 cells/ml were seededin six-wellplatesandincubateduntil80%confluency.Cellswere pre-treated withgastrodin (30, 40, and60 mM)for1 h,then
exposed to 1 mg/ml LPS for 4 h. The levels of protein and the corresponding mRNA were determined by double-immunofluorescence labeling and RT-
PCR as described in the Methods. PanelA shows the immunofluorenscence images for protein expression of IL-1b andPanelB shows the corresponding
mRNA data. The relative mRNA level was quantified by scanning densitometry and normalized to b-actin mRNA. The values shown are mean 6 SEM of
data from three independent experiments.
# Significant compared with control alone, p,0.05.
*Significant compared with LPS alone, p,0.05.
doi:10.1371/journal.pone.0021891.g005
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disease conditions, attenuate neuronal degeneration [32,33]. The
present study demonstrates, for the first time, that gastrodin, a
constituent of the traditional Chinese herb Tianma (Gastrodin
elata Bl.), significantly inhibits LPS-induced enhancement of
expression of proinflammatory enzymes (iNOS and COX-2) and
proinflammatory cytokines (TNF-a and IL-1b) in microglial cells,
at both mRNA and protein levels, providing an underlying
mechanism for the neuroprotective effects of gastrodin in vitro.
COX-1 is constitutively expressed in most tissues, while COX-2
is induced by an array of stimuli including cytokines, LPS, and
growth factor in microglia and astrocytes [12,34]. COX-2 is the
key enzyme in the formation of prostaglandins (PGs) during
inflammatory conditions [18]. Although the relationship between
microglial activation and neurodegenerative disease is not
completely understood, it is well accepted that microglial
activation is involved in the pathogenesis of various neurological
and neurodegenerative diseases [35,36]. In addition, microglial
cells in the healthy brain do not express iNOS, but they become
activated to produce iNOS and release a large amount of NO
following ischemic, traumatic, neurotoxic or inflammatory dam-
age [12,37,38,39]. Increased NO production in the brain by
prolonged activation of microglial cells is associated with
progression of neurodegenerative disease [14]. Therefore, any
substance that can attenuate expression of iNOS and COX-2
would be beneficial for delaying the progression of neurodegen-
erative disease. In the present study, gastrodin (30, 40, and 60 mM)
significantly inhibited the protein and mRNA expression of iNOS
and COX-2 in a dose-dependent manner in LPS-stimulated BV-2
microglial cells, suggesting possible beneficial effects of gastrodin
by attenuating the activation of microglial cells and subsequent
production of inflammatory mediators.
TNF-a and IL-1b are two main proinflammatory cytokines that
are produced by activated microglia during CNS inflammation. In
the CNS, a number of stimuli, such as LPS, b-amyloid and
traumatic brain injury have been shown to abundantly produce
TNF-a and IL-1b [40,41]. Overproduction of proinflammatory
cytokines from activated microglial cells has a detrimental effect on
neuronal cells. This study investigated whether gastrodin inhibits
LPS-induced production of proinflammatory cytokines in BV-2
cells. Our data suggest that gastrodin inhibited LPS-induced
production of TNF-a and IL-1b in a dose-dependent manner.
Gastrodin also attenuated their mRNA expression in LPS-
stimulated BV-2 cells. These results suggest that gastrodin
inhibited the production of proinflammatory cytokines through
the regulation of their gene transcriptional levels in activated BV-2
cells.
The transcriptional regulation of iNOS, COX-2 and inflam-
matory cytokines, such as TNF-a and IL-1b, is a tightly controlled
event. A variety of transcription factors, including NF-kB and
CREB, is known to be involved in the transcriptional regulation of
these inflammatory mediators [42]. NF-kB and CREB are
important regulators of the expression of these inflammatory
mediators [43,44,45]. In un-stimulated cells, NF-kB is retained in
the cytoplasm by binding to IkB-a. Activation of NF-kB occurs via
phosphorylation of its endogenous inhibitor IkB-a that resulting in
the release and nuclear translocation of active NF-kB. The
molecular mechanisms underlying anti-inflammatory effect of
gastrodin, which showed the most potent anti-inflammatory
activity, were further studied. The results suggest that LPS
induced expression of NF-kB/RelA protein within 4 h after
stimulation, which was inhibited by gastrodin as determined by a
double-immunofluorescence labeling and RT-PCR assay. Mean-
while, BV-2 cells were pre-treated with gastrodin for 1 h and then
stimulated with LPS for 30 min. Gastrodin suppressed the LPS-
induced phosphorylation of IkB-a and CREB. These results
indicated that the inhibition of gastrodin on the expression of
iNOS, COX-2 and proinflammatory cytokines is partially through
the suppression of NF-kB/RelA expression, the phosphorylation
of IkB-a and CREB in LPS-stimulated BV-2 cells.
Figure 6. Inhibitory effects of gastrodin on the LPS-induced expression of protein and mRNA for NF-kB/RelA in BV-2 cells.
Approximately 1610
6 cells/ml were seeded in six-well plates and incubated until 80% confluency. Cells were pre-treated with gastrodin (30, 40, and
60 mM) for 1 h, then exposed to 1 mg/ml LPS for 4 h. The levels of protein and the corresponding mRNA were determined by double-
immunofluorescence labeling and RT-PCR as described in the Methods. Panel A shows the immunofluorenscence images for protein expression of
NF-kB/RelA and Panel B shows the corresponding mRNA data. The relative mRNA level was quantified by scanning densitometry and normalized to
b-actin mRNA. The values shown are mean 6 SEM of data from three independent experiments.
# Significant compared with control alone, p,0.05.
*Significant compared with LPS alone, p,0.05.
doi:10.1371/journal.pone.0021891.g006
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induced iNOS, COX-2, and proinflammatory cytokines expression
inmanytypes ofcells [46,47,48]. Italso has been reported that LPS-
induced expression of proinflammatory cytokines expression is
mediated by MAPKs signal transduction pathway in BV-2 cells
[34]. Therefore, we investigated the effect of gastrodin on activation
(phosphorylation) of three MAPKs induced by LPS in BV-2 cells. In
our study, LPS increased activation of MAPKs, including ERK1/2,
JNK, and p38 MAPK, within 30 min after stimulation, whereas
gastrodin decreased LPS-induced activation of MAPKs, which was
accompanied by alterations in iNOS, COX-2, and proinflamma-
tory cytokines. These results suggested that gastrodin-mediated
attenuation of proinflammatory mediators is associated with down-
regulation of the MAPK signaling pathway.
The present results have shown that gastrodin significantly
suppressed LPS-upregulated expression levels of iNOS, COX-2,
Figure 7. Inhibitory effects of gastrodin on the LPS-induced phosphorylation expression of IkB-a(A), CREB (B), ERK1/2 (C), JNK(D)
and p38 MAPK (E) in BV-2 cells. Approximately 1610
6 cells/ml were seeded in six-well plates and incubated until 80% confluency. Cells were pre-
treated with gastrodin (30, 40, and 60 mM) for 1 h, then exposed to 1 mg/ml LPS for 30 min. Cell lysates (50 mg protein) were prepared and subjected
to Western blot analysis by using antibodies specific for phosphorylated forms of IkB-a, CREB, ERK1/2, JNK and p38 MAPK (shown as phospho-IkB-a,
etc.) as described in the methods. Equivalent loading of cell lysates was determined by reprobing the blots with anti-b-actin, total ERK1/2, JNK or p38
MAPK antibodies. The relative protein levels were quantified by scanning densitometry and normalized to b-actin, total ERK1/2, JNK or p38 MAPK. The
values shown are mean 6 SEM of data from three independent experiments.
# Significant compared with control alone, p,0.05.
*Significant
compared with LPS alone, p,0.05.
doi:10.1371/journal.pone.0021891.g007
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dose dependent manner; on the other hand, its inhibitory effects
were not followed dose dependently in the mRNA expression of
these biomarkers. The same phenomenon was manifested by the
inhibitory effects on phosphorylation of IkB-a, CREB, MAPKs
including ERK1/2, JNK and p38 MAPK. Hence, while the
inhibitory effects of gastrodin on the above-mentioned various
cytokines and enzymes linked to various signaling routes are
unequivocal, the actual mechanistic link between them remains to
be fully elucidated. In view of the fact that gastrodin did not inhibit
phosphorylation of IkB-a or the various signaling routes in a dose
dependent manner, the possibility that other pathways by which
gastrodin can regulate the target proteins investigated should be
considered. In addition, it needs to be pointed out that the
inhibitory changes as observed in this study were based on a single
time point. Considering the effects of LPS and gastrodin develop
over a significant period of time, a time course study to investigate
these time-related aspects would appear to be important.
In conclusion, we show here the inhibitory effects of gastrodin
on LPS-induced proinflammatory mediators in microglial BV-2
cells. In this connection, gastrodin significantly attenuated the
expression levels of neurotoxic proinflammatory mediators,
including iNOS, COX-2, and proinflammatory cytokines (TNF-
a and IL-1b) in LPS-stimulated microglial cells. This was
accompanied by attenuation of expression levels of NF-kB/RelA
protein and phosphorylation of IkB-a and CREB. Furthermore,
levels of phosphorylated MAPKs, including ERK1/2, JNK, and
p38 MAPK, were significantly decreased by pre-treatment with
gastrodin in LPS-stimulated microglial cells. Taken together, these
results indicate that gastrodin exerts its anti-inflammatory actions
by inhibition of the NF-kB signaling pathway and phosphorylation
of MAPKs. Arising from the above, we suggest that gastrodin is a
potential an anti-inflammatory drug candidate in neurodegener-
ative diseases.
Methods
Cells and treatments
The immortalized mouse microglial cell line BV-2 was
developed in the laboratory of Dr Blasi at the University of
Perugia [49] and was a generous gift of Dr Cheng-gang Zou
(School of Life Science, Yunnan University, Kunming, China).
Cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; Gibco/BRL, Gaithersburg, MD, USA) containing 2%
fetal bovine serum (Hyclone, Logan, UT, USA) and antibiotics
(100 IU/ml penicillin and 100 mg/ml streptomycin; Sigma, St.
Louis, MO, USA) at a density not exceeding 5610
5 cells/ml and
maintained at 37uC in a humidified incubator with 5% CO2.T o
harvest BV-2 cells, cells were trypsinized (0.25% trypsin/EDTA in
phosphate-buffered saline (PBS); Sigma, St. Louis, MO, USA),
then centrifuged (400 g for 10 min) and resuspended in serum-free
DMEM. Cells were counted with a hemocytometer and trypan
blue staining (0.4% trypan blue in PBS; Sigma) showed more than
99% of the cells retained viability. Cells (approximately 1610
6
cells/ml) were seeded in six-well plates before being subjected to
treatments. Five groups of BV-2 cells were subjected to various
treatments. In group 1, the cells were incubated in serum-free
DMEM. In group 2, the cells were treated with 1 mg/ml LPS
(from Escherichia coli, Sigma). In groups 3, 4, and 5, the cells were
treated with 30 mM, 40 mM, and 60 mM gastrodin (Kunming
Pharmaceutical Corporation, Kunming, China) for 1 h and then
stimulated with LPS (1 mg/ml). This time point was chosen to
minimize the possibility of any direct interactions between
gastrodin and LPS. Cell incubations were for 30 min–4 h, as
indicated in the text.
Double-immunofluorescence labeling assay
Various treated BV-2 cells were fixed with 4% paraformalde-
hyde in 0.1 M phosphate buffer (PB) for 15 min. After rinsing with
PBS, the coverslips with adherent cells were used for double-
immunofluorescence labeling assay. BV-2 cells were incubated
with DAPI (dilution 1:50,000; Sigma) plus goat anti-mouse iNOS
(dilution 1:500; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), goat anti-mouse COX-2 (dilution 1:500; Santa Cruz
Biotechnology), goat anti-rabbit TNF-a polyclonal antibody
(dilution 1:500; Chemicon, Temecula, CA, USA), goat anti-rabbit
IL-1b (dilution 1:500; Chemicon), or goat anti-rabbit NF-kB/
RelA (dilution 1:500; Santa Cruz Biotechnology). Subsequently,
the cells were incubated with TRITC-conjugated secondary
antibodies (Santa Cruz Biotechnology) for 1 h at room temper-
ature. For negative controls, a set of culture slides was incubated
under similar conditions without the primary antibodies. All
images were captured with a fluorescence microscope (D80i;
Nikon, Tokyo, Japan). The results are representative of three
independent experiments.
Reverse transcription-polymerase chain reaction (RT-PCR)
analysis
Total RNA was prepared from BV-2 cells by using the TrizolH
reagent (Invitrogen Corporation, Carlsbad, CA, USA) according
to the manufacturer’s protocol. Total RNA was reverse-tran-
scribed by using the Superscript
TM-III kit (Invitrogen) with 2.5 mg
total RNA and oligo dT. Primer sequences were as follows: iNOS,
sense: 59- CTGCAGCACTTGGATCAGGAACC TG -39, anti-
sense: 59- GGGAGTAGCCTGTGTGCACCTGGAA -39; COX-
2, sense: 59-TTGAAGACCAGGAGTACAGC-39, antisense: 59-
GGTACAGTTCCATGACATCG-39; TNF-a, sense: 59-CG-
TCAGCCGATTTGCTATCT-39, antisense: 59-CGGACTCCG-
CAAA GTCTAAG-39; IL-1b, sense: 59-GCCCATCCTCTGT-
GACTCAT-39, antisense: 59-AGGCCAC AGGTATTTTGT-
CG-39; NF-kB/RelA, sense: 59-GCGTACACATTCTGGG-
GAGT-39, antisense: 59-CCGAAGCAGGAGCTATCAAC-39;
b-actin, sense: 59-AGCCATGTACGTAGCCATCC-39, anti-
sense: 59-GCTGTGGTGGTGAAGCTGTA-39. PCR amplifica-
tion of the resulting cDNA template was conducted by using the
following conditions for 45 (TNF-a, IL-1b, NF-kB/RelA and b-
actin), 36 (COX-2) or 27 (iNOS) cycles. After an initial
denaturation step at 95uC for 15 min, temperature cycling was
initiated. Each cycle consisted of denaturation at 94uC for 15 sec,
annealing at 60uC for 25 sec, and elongation at 72uC for 20 sec
(TNF-a, IL-1b, NF-kB/RelA and b-actin). After an initial
denaturation step at 95uC for 5 min, temperature cycling was
initiated. Each cycle consisted of denaturation at 94uC for 30 sec,
annealing at 57uC for 45 sec, and elongation at 72uC for 30 sec
(COX-2). After an initial denaturation step at 95uC for 5 min,
temperature cycling was initiated. Each cycle consisted of
denaturation at 94uC for 45 sec, annealing at 60uC for 45 sec,
and elongation at 70uC for 1 min (iNOS). PCR products were
analyzed on 1% agarose gels and stained with 1 mg/ml ethidium
bromide. Images were captured with a Gel Doc 2000 image
analyzer (Bio-Rad, Richmond, CA, USA). The results are
representative of three independent experiments.
Western blot analysis
BV-2 cells were plated overnight in 6 well plates at a density of
5610
5 cells per plate, then the cells were further incubated in the
Gastrodin Inhibits Activation of Microglia by LPS
PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e21891medium without 10% FBS for at least 4 h before treatments. Cells
were harvested with ice-cold PBS and centrifuged at 16 0006g for
5 min at 4uC. Stimulated cells were lysed in ice-cold lysis buffer
[62.5 mM Tris–HCl, pH 6.8, 25% glycerol, 2% sodium dodecyl
sulphate (SDS), 0.01% bromphenol blue and 5% b-mercaptoeth-
anol]. Cell lysates were centrifuged at 16 0006g for 5 min at 4uC,
then the supernatants were collected. Protein content was
determined by using the BCA protein assay (Pierce, Rockford,
IL, USA). Equal amounts of protein (50 mg) were loaded per lane
onto 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto immunoblot polyvinylidene difluoride
membranes (Chemicon). The membranes were blocked with 5%
non-fat milk in Tris-buffered saline containing 0.1% Tween 20
(TBS-T) for 2 h at room temperature and incubated separately
with goat anti-rabbit antibodies for ERK1/2 and phospho-
ERK1/2, JNK and phospho-JNK, p38 MAPK and phospho-
p38 MAPK, phospho-IkB-a, phospho-CREB and b-actin anti-
bodies (1:1000 dilution; Cell Signaling Technology, Danvers, MA,
USA) that recognize different molecules under study for overnight
at 4uC. The membranes were then washed three times for 15 min
with TBS-T, and incubated with a 1:2000 dilution of horseradish
peroxidase-coupled secondary antibodies (Santa Cruz Biotechnol-
ogy) for 2 h at room temperature. Blots were again washed three
times for 5 min each in TBS-T and developed by the ECLH
detection system (Santa Cruz Biotechnology). Membranes were
exposed to Fuji Medical X-Ray Film (Fuji Photo Film Co., Ltd,
Karagawa, Japan). The results are representative of three
independent experiments.
Statistical analysis
Statistical analysis of the data was carried out by one way
analysis of variance (ANOVA) followed by Scheffe’s post hoc test,
using SPSS (SPSS Inc., Chicago, IL, USA). Summary data are
shown as mean 6 SEM (standard error of mean) obtained from
three independent experiments. Values of p,0.05 were considered
significant.
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